SMITHKLINE BEECHAM RELAFEN DIRECT-TO-CONSUMER ADS BREAKING IN MID-MARCH
SMITHKLINE BEECHAM RELAFEN DIRECT-TO-CONSUMER ADS BREAKING IN MID-MARCH issues of Reader's Digest, American Health, Time and U.S. News and World Report, SmithKline Beecham announced Feb. 23. The print ads will refer readers to a toll-free number (800-734- 1543) to call for an information booklet about the nonsteroidal anti-inflammatory drug Relafen (nabumetone). The ads were designed by Ogilvy & Mather.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth